Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Acetylcholinesterase deficiency decreases apoptosis in dopaminergic neurons in the neurotoxin model of Parkinson's disease.

Zhang X, Lu L, Liu S, Ye W, Wu J, Zhang X.

Int J Biochem Cell Biol. 2013 Feb;45(2):265-72. doi: 10.1016/j.biocel.2012.11.015. Epub 2012 Nov 29.

PMID:
23201480
3.

Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease.

Viswanath V, Wu Y, Boonplueang R, Chen S, Stevenson FF, Yantiri F, Yang L, Beal MF, Andersen JK.

J Neurosci. 2001 Dec 15;21(24):9519-28.

4.

Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Hayley S, Crocker SJ, Smith PD, Shree T, Jackson-Lewis V, Przedborski S, Mount M, Slack R, Anisman H, Park DS.

J Neurosci. 2004 Feb 25;24(8):2045-53.

5.

Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.

Kim NK, Choi BH, Huang X, Snyder BJ, Bukhari S, Kong TH, Park H, Park HC, Park SR, Ha Y.

Eur J Neurosci. 2009 Mar;29(5):891-900. doi: 10.1111/j.1460-9568.2009.06653.x. Epub 2009 Feb 24.

PMID:
19245369
6.

Caspase-11 mediates inflammatory dopaminergic cell death in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Furuya T, Hayakawa H, Yamada M, Yoshimi K, Hisahara S, Miura M, Mizuno Y, Mochizuki H.

J Neurosci. 2004 Feb 25;24(8):1865-72.

7.

Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.

Meuer K, Pitzer C, Teismann P, Krüger C, Göricke B, Laage R, Lingor P, Peters K, Schlachetzki JC, Kobayashi K, Dietz GP, Weber D, Ferger B, Schäbitz WR, Bach A, Schulz JB, Bähr M, Schneider A, Weishaupt JH.

J Neurochem. 2006 May;97(3):675-86. Epub 2006 Mar 29.

8.

A novel compound PTIQ protects the nigral dopaminergic neurones in an animal model of Parkinson's disease induced by MPTP.

Son HJ, Lee JA, Shin N, Choi JH, Seo JW, Chi DY, Lee CS, Kim EM, Choe H, Hwang O.

Br J Pharmacol. 2012 Apr;165(7):2213-27. doi: 10.1111/j.1476-5381.2011.01692.x.

9.

CGP 3466 protects dopaminergic neurons in lesion models of Parkinson's disease.

Waldmeier PC, Spooren WP, Hengerer B.

Naunyn Schmiedebergs Arch Pharmacol. 2000 Dec;362(6):526-37.

PMID:
11138845
10.

Soluble Epoxide Hydrolase Deficiency or Inhibition Attenuates MPTP-Induced Parkinsonism.

Qin X, Wu Q, Lin L, Sun A, Liu S, Li X, Cao X, Gao T, Luo P, Zhu X, Wang X.

Mol Neurobiol. 2015 Aug;52(1):187-95. doi: 10.1007/s12035-014-8833-3. Epub 2014 Aug 17.

PMID:
25128026
11.

Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway.

Zhai A, Zhu X, Wang X, Chen R, Wang H.

Eur J Pharmacol. 2013 Aug 5;713(1-3):58-67. doi: 10.1016/j.ejphar.2013.04.029. Epub 2013 May 9.

PMID:
23665112
13.

Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.

Turmel H, Hartmann A, Parain K, Douhou A, Srinivasan A, Agid Y, Hirsch EC.

Mov Disord. 2001 Mar;16(2):185-9.

PMID:
11295768
14.

Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Eberhardt O, Coelln RV, Kugler S, Lindenau J, Rathke-Hartlieb S, Gerhardt E, Haid S, Isenmann S, Gravel C, Srinivasan A, Bahr M, Weller M, Dichgans J, Schulz JB.

J Neurosci. 2000 Dec 15;20(24):9126-34.

15.

Hexokinase II gene transfer protects against neurodegeneration in the rotenone and MPTP mouse models of Parkinson's disease.

Corona JC, Gimenez-Cassina A, Lim F, Díaz-Nido J.

J Neurosci Res. 2010 Jul;88(9):1943-50. doi: 10.1002/jnr.22357.

PMID:
20143419
16.
17.

Eldepryl prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigral neuronal apoptosis in mice.

Guo M, Chen S, Liu Z, Chen H.

Chin Med J (Engl). 2001 Mar;114(3):240-3.

PMID:
11780305
18.

Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease.

Anandhan A, Tamilselvam K, Radhiga T, Rao S, Essa MM, Manivasagam T.

Brain Res. 2012 Jan 18;1433:104-13. doi: 10.1016/j.brainres.2011.11.021. Epub 2011 Nov 13.

PMID:
22138428
19.

PEP-1-heat shock protein 27 protects from neuronal damage in cells and in a Parkinson's disease mouse model.

Lee YP, Kim DW, Kang HW, Hwang JH, Jeong HJ, Sohn EJ, Kim MJ, Ahn EH, Shin MJ, Kim DS, Kang TC, Kwon OS, Cho SW, Park J, Eum WS, Choi SY.

FEBS J. 2012 Jun;279(11):1929-42. doi: 10.1111/j.1742-4658.2012.08574.x. Epub 2012 Apr 16.

20.

Supplemental Content

Support Center